Fintel reports that on February 2, 2026, Guggenheim initiated coverage of Cullinan Therapeutics (NasdaqGS:CGEM) with a Buy ...
"In this 'Skyspace,' the day has weight, the evening has temperature, and the change belongs to you," Turrell says.